# FMT in Cirrhosis and Hepatic Encephalopathy

> **NCT03796598** · PHASE1,PHASE2 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 60 (actual)

## Conditions studied

- Cirrhosis
- Hepatic Encephalopathy

## Interventions

- **DRUG:** Fecal Microbial transplant Capsules
- **DRUG:** Fecal Microbial Transplant Enema
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03796598
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-29
- **Primary completion:** 2023-12-19
- **Final completion:** 2023-12-20
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03796598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03796598, "FMT in Cirrhosis and Hepatic Encephalopathy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03796598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*